Hyundai ADM Bio Inc. (KOSDAQ:187660)

Hyundai ADM Bio Statistics

Total Valuation

Hyundai ADM Bio has a market cap or net worth of KRW 142.17 billion. The enterprise value is 145.42 billion.

Market Cap	142.17B
Enterprise Value	145.42B

Important Dates

The next estimated earnings date is Wednesday, December 10, 2025.

Earnings Date	Dec 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Hyundai ADM Bio has 50.24 million shares outstanding.

Current Share Class	50.24M
Shares Outstanding	50.24M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.50%
Owned by Institutions (%)	n/a
Float	31.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.59
PB Ratio	21.45
P/TBV Ratio	21.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.24
EV / Sales	14.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.14

Financial Position

The company has a current ratio of 0.55, with a Debt / Equity ratio of 1.40.

Current Ratio	0.55
Quick Ratio	0.35
Debt / Equity	1.40
Debt / EBITDA	n/a
Debt / FCF	-0.65
Interest Coverage	-13.69

Financial Efficiency

Return on equity (ROE) is -88.95% and return on invested capital (ROIC) is -39.46%.

Return on Equity (ROE)	-88.95%
Return on Assets (ROA)	-27.49%
Return on Invested Capital (ROIC)	-39.46%
Return on Capital Employed (ROCE)	-200.38%
Revenue Per Employee	60.91M
Profits Per Employee	-125.60M
Employee Count	160
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	-138.12M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.43% in the last 52 weeks. The beta is 0.82, so Hyundai ADM Bio's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+61.43%
50-Day Moving Average	2,649.34
200-Day Moving Average	1,994.16
Relative Strength Index (RSI)	48.56
Average Volume (20 Days)	5,601,064

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hyundai ADM Bio had revenue of KRW 9.74 billion and -20.10 billion in losses. Loss per share was -475.02.

Revenue	9.74B
Gross Profit	57.97M
Operating Income	-15.99B
Pretax Income	-18.23B
Net Income	-20.10B
EBITDA	-14.41B
EBIT	-15.99B
Loss Per Share	-475.02

Balance Sheet

The company has 5.84 billion in cash and 9.29 billion in debt, giving a net cash position of -3.44 billion or -68.57 per share.

Cash & Cash Equivalents	5.84B
Total Debt	9.29B
Net Cash	-3.44B
Net Cash Per Share	-68.57
Equity (Book Value)	6.63B
Book Value Per Share	161.33
Working Capital	-9.23B

Cash Flow

In the last 12 months, operating cash flow was -14.29 billion and capital expenditures -53.88 million, giving a free cash flow of -14.35 billion.

Operating Cash Flow	-14.29B
Capital Expenditures	-53.88M
Free Cash Flow	-14.35B
FCF Per Share	-285.58

Margins

Gross margin is 0.59%, with operating and profit margins of -164.13% and -206.22%.

Gross Margin	0.59%
Operating Margin	-164.13%
Pretax Margin	-187.09%
Profit Margin	-206.22%
EBITDA Margin	-147.82%
EBIT Margin	-164.13%
FCF Margin	n/a

Dividends & Yields

Hyundai ADM Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-14.14%
FCF Yield	-10.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 27, 2024. It was a forward split with a ratio of 2.

Last Split Date	Nov 27, 2024
Split Type	Forward
Split Ratio	2

Scores

Hyundai ADM Bio has an Altman Z-Score of -0.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.68
Piotroski F-Score	1